Evaluation of the male reproductive organs after treatment with continuous sustained delivery of statin for fracture healing

Biomedical Sciences Instrumentation

Volumn 41, Issue , 2005, Pages 54-61

  Adah, Felix ^a   Benghuzzi, Hamed ^a   Tucci, Michelle ^a   Russell, George ^a   Tsao, Audrey ^a   Olivier, Jake ^a   England, Barry ^b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Drug Delivery System; Fracture; Healing; Osteogenic agent; Simvastatin; Statins; Tricalcium Phosphate Lysine

Indexed keywords

BIOTECHNOLOGY; BONE; CHOLESTEROL; ENZYME INHIBITION; ENZYMES; FRACTURE; MORPHOLOGY;

ANIMAL DATA; MALE REPRODUCTIVE ORGANS; REDUCTASE INHIBITORS; STATINS;

BIOLOGICAL ORGANS;

DRUG CARRIER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BODY WEIGHT; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG RELEASE; ENDOCRINE FUNCTION; EVALUATION; FEMUR FRACTURE; FOLLITROPIN BLOOD LEVEL; FRACTURE HEALING; GENITAL SYSTEM; HORMONE BLOOD LEVEL; LONG TERM CARE; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MORPHOLOGY; NONHUMAN; RAT; REPRODUCTION; STEROIDOGENESIS; TESTOSTERONE BLOOD LEVEL;

ANIMALS; CHOLESTEROL; DELAYED-ACTION PREPARATIONS; FEMORAL FRACTURES; FRACTURE HEALING; GENITALIA, MALE; GONADAL HORMONES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; RATS; RATS, SPRAGUE-DAWLEY; SIMVASTATIN; TREATMENT OUTCOME;

EID: 17044435414     PISSN: 00678856     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (37)

1. rd. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation. Journal of Bone & Mineral Research. 1997;12(1):24-35.
2. Bouletreau, PJ, Warren, SM, and Longaker, MT. The molecular biology of distraction osteogenesis. J Craniomaxillofac Surg. 2002;30(1):1-11.
3. Peter, CP, Cook, WO, Numamaker, DM, Provost, MT, Seedor, JG, and Rodan, GA. Effects of alendronate on fracture healing and bone remodeling in dog. Journal of Orthopaedic Research. 1996;14(1):74-79.
4. Mundy, G, Garrett, R, Harris, S, Chan, J, Chen, G, Rossini, G, Boyce, B, Zhao, M, and Gutierrez, G. Stimulation of bone formation in vitro and in rodents by statins. Science. 1999;286:946-1949.
5. Ohnaka, K, Shimoda, S, Nawata, H, Shimokawa, H, Kaibuchi K, Iwamoto, Y, and Takayanagi, R. Pitavastatin enchanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts. Biochem Biophys Res Commun. 2001;287(2):337-342.
6. Garrett, R, and Mundy, GR. The role of statins as potential targets for bone formation. Arthritis Res. 2002;4(4):237-240.
7. Staal, A, Frith, JC, French, MH, Swartz, J, Gungor, T, Harrity, TW, Tamasi, J, Rogers, and Feyen, JH. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity. J Bone Miner Res. 2003;18(1):88-96.
8. Edwards, CJ, and Spector, TD, (2002). Statins and modulators of bone formation. Arthritis Res. 2002;4(3):151-153.
9. Sica, DA, and Gehr, TW. Rhabdomyolysis and statin therapy: Relevance to the elderly. Am J Geriatr Cardiol. 2002;1(1):48-55.
10. Corsini, A Bellosta, S, Baetta, R, Fumagalli, R, Paoletti, R, and Bernini, F. New insights into the pharmacodynamic and pharmacokinetic properties of statins. Pharmacol Ther. 2000;84(3):413-428.
11. Bauer, DC, Mundy, GR, Jamal, SA, Black, DM, Cauley, JA, Insrud, KE, van der Klift, M, and Pols, HA. Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials. Arch Inter Med. 2004;164(2):146-152.
12. Meier, CR, Schlienger, RG, Kraenzlin, ME, Schlegel, B, and Jick, H. HMG-CoA reductase inhibitors and the risk of fractures. JAMA. 2000;283(24):3205-3210.
13. Wang, PS, Solomon, DH, Mogun, H, and Avorn, J. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients.(comment). JAMA. 2000;283(24):3211-3216.
14. Chan, KA, Andrad, SE, Boles, M, Buist, DSM, Chase, GA, Donahue, JG, Goddman, MJ, Gurwitz, JH, LaCroix, AZ, and Platt, R. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. The Lancet. 2002;355(9222):2185-2188.
15. Edwards, CJ, Hart, DJ, and Spector, TD. Oral stains and increased bone-mineral density in post-menopausal women. Lancet. 2000;355(9222):2218-2219.
16. Reid, IR, Hague, W, Emberson, J, Baker, J, Tonkin, A, Hunt, D, MacMahon, S, and Sharpe, N. Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomized controlled trial. Long term intervention with pravastatin in ischaemic disease. Lancet, 2001;357(9255):509- 512.
17. Van Staal, TP, Wegman, S, de Varies, F, Leufkens, B, and Cooper, C. Use of statins and risk of fractures. JAMA. 2001;285:1850-1855.
18. Oxlund, H, Dalstra, M, and Andressen, TT. Statin given perorally to adult rats increases cancellous bone mass and compressive strength. Calcified Tissue International. 2001;69(5):299-304.
19. Travia, D, Tosi, F, Negri, C, Faccini, G, Moghetti, P, and Muggeo, M, (1995). Sustained therapy with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitors does not impair steroidogenesis by adrenals and gonads. J Clin Endocrinol Metab. 80(3):836-840.
20. Santini, SA, Carozza, C, Luli, P, Zuppi, C, Caro, TG, and Musumeci, S (2003). Atorvastatin treatment does not affect gonadal and adrenal hormones in type 2 diabetes patients with mild to moderate hypercholesterolemia. J Atheroscler Thromb. 10(3):160-164.
21. Purvis, K, Tollefsrud, A, Rui, H, Haug, E, Norseth, J, Viksmoen, L, and Lund, H, (1992). Short-term effects of treatment with simvastatin on testicular function in patients with heterozygous familial hypercholesterolaemia. Eur J Clin Pharmacol. 42(1):61-64.
22. Benghuzzi, H. The effect of sustained delivery of androstendion on the functional activities of adult male rats. Biomedical Sciences Instrumentation. 1998;34:7-12.
23. Benghuzzi, HA, and England, BG. The effect of sustained delivery of danazol and antioxidants on lipoprotein profiles of adult female mice. Biomedical Sciences Instrumentation. 1995;31:171-176.
24. Cavett, W, Tucci, M, Cason, Z, Lemos, L, and England, B. Cellular responses to various levels of sustained delivery of testosterone in the ventral prostate. Biomedical Sciences Instrumentation. 1997;33:155-160.
25. Varnado, M, Tucci, M, Cason, Z, Mohamed, A, and Benghuzzi, H. Germinal cell alterations associated with sustained delivery of testosterone enanthate in adult male rats. Biomedical Sciences Instrumentation. 1997;33:161-165.
26. Nagy, EA, and Bajpai, PK. Development of a ceramic matrix system for continuous delivery of azidothymidine. Biomedical Sciences Instrumentation. 1994;30:181-186.
27. England, BG, Benghuzzi, HA, Possley, RM, and Bajpai, PK. The effect of various testosterone concentrations released from ceramic delivery systems on the circulating hormone levels of adult castrated rams. Biomedical Sciences Instrumentation. 1991;27:89-195.
28. Benghuzzi, HA, England, BG, and Bajpai, PK. Tricalcium phosphate amino acid capsules as a drug delivery system for steroid hormones. Biomedical Sciences Instrumentation. 1991;27:197-203.
29. Benghuzzi, HA, Barbara, RM, and Bajpai, PK. In vitro release of azidothymidine (AZT) by ceramic drug delivery. Biomedical Sciences Instrumentation. 1990;26:151-156.
30. Benghuzzi, HA, Possley, R, and England, BG. Pulsatile delivery of progesterone and estradiol to mimic the ovulatory surge in adult ewes by means of TCPL implants. Biomedical Sciences Instrumentation. 1994;30:187-196.
31. Conflitti, J, Graves, M, Russell, G, Tucci, M, and Benghuzzi, H. Plating of rat femoral shaft osteotomies: Report of a technique and preliminary results. Biomedical Sciences Instrumentation. 2003;39:278-283.
32. Nixon, A, Benghuzzi, H, and Cason, Z, (2003). Morphometric evaluation of ovarian tissue exposed to PCB conventionally and in a sustained manner. Biomedical Sciences Instrumentation. (39): 434-439.
33. Benghuzzi, H, Tucci, Eckie, R, and Hughes, J, (2003). The effects of sustained delivery of diosgenin on the adrenal gland of female rats. Biomedical Sciences Instrumentation. 39: 335-340.
34. Gordon, E, Lasserre, A, Stull, P, Bajpai, PK, (1997). A zinc based self-setting ceramic bone substitute for local delivery of testosterone. Biomedical Sciences Instrumentation, 33: 131-136.
35. Thylin, MR, McConnell, JC, Schmid, MJ, Reckling, RR, Ojha, J, Bhattacharyya, I, Marx, DB, and Reinhardt, RA. Effects of simvastatin gels on murine calvarial bone. Journal of Periodontology. 2002;73(10):1141-1148.
36. Skoglund, B, Forslund, C, and Aspenberg, P. Simvastatin improves fracture healing in mice. J Bone Miner Res. 2002;(11):2004-2008.
37. Guliaeva, NV, and Levshina, IP, (1988). Characteristics of free-radical oxidation and antiradical protection of the brain in adaptatin to chronic Stress. Biull Eksp Biol Med. 106(8):153-156.